Philips completes acquisition of BioTelemetry

Subscribe to YouTube Channel

Subscribe to Mojo4Industry YouTube Channel and get Latest Industry Updates. Do press Bell Icon to get automated notifications whenever new video is uploaded.

Must Read

TCS to help Skanska become a more digitally advanced construction company

TCS to help Skanska become a more digitally advanced construction company Tata Consultancy Services (TCS), a leading global IT services,...

ELECRAMA 2023 space booking opens from May 16

ELECRAMA 2023 space booking opens from May 16 Indian Electrical and Electronics Manufacturers Association announced space booking commencement of its...

Vedanta rolls out scheme for MSMEs under ‘Saathi’ programme

Vedanta rolls out scheme for MSMEs under ‘Saathi’ programme Vedanta Limited has rolled out an attractive promotional scheme for Micro, Small...

Philips completes acquisition of BioTelemetry

Royal Philips announced that it has completed the acquisition of BioTelemetry, Inc., an U.S.-based provider of remote cardiac diagnostics and monitoring. BioTelemetry’s financial results will be consolidated as part of Philips’ Connected Care business segment as of February 9.

The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions. Philips’ patient care management solutions for the hospital include real-time patient monitoring, therapeutic devices, telehealth and informatics. Moreover, Philips has an advanced and secure cloud-based Philips HealthSuite digital platform optimized for the delivery of health care across care settings.

With 2020 sales of USD 450 million, BioTelemetry adds a complete range of clinically validated ambulatory cardiac diagnostics and monitoring services: Short-term Holter monitoring services, Long-term Holter monitoring services, Event recorder services, and Mobile Cardiac Outpatient Telemetry (MCOT) services. BioTelemetry has built one of the world’s largest remote cardiac monitoring services networks, providing services for over one million patients per year. Additionally, BioTelemetry has a clinical research business that provides testing services for clinical trials.

“The combination of Philips’ leading patient care management portfolio in the hospital with BioTelemetry’s leading cardiac diagnostics and monitoring portfolio outside the hospital will result in a global leader in patient care management solutions for the hospital and the home for cardiac and other patients,” said Frans van Houten, CEO of Royal Philips. “With our collective portfolios, and our healthcare informatics and services platforms, we will be in an optimal position to improve patient care across care settings for multiple diseases and medical conditions.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

is banner
- Advertisement -
our advertiser v2

Tech Talks

00:06:46

CII EXCON 2021 | Day 4 | Highlights

CII EXCON 2021 | Day 4 | Highlights The 11th edition of CII EXCON, South Asia’s largest construction equipment trade...
- Advertisement -
print v2

More Stories on mojo4industry